相关实验视频

Updated: Jun 9, 2026

A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments

A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments

Published on: November 9, 2017

与免疫调节药物相关的外围神经病变:基于FDA不良事件报告系统数据库的药监测分析

Chunhong Liang¹, Xueyan Zhang², Lijuan Zhou²

¹Office of Drug Clinical Trial Institution, Sixth Affiliated Hospital of Guangxi Medical University, Yulin, 537000, Guangxi, China.

International journal of clinical pharmacy

|May 20, 2025

概括

像thalidomide,lenalidomide和pomalidomide这样的免疫调节药物 (IMiD) 与外围神经病变有关. 风险因药物,患者指示和年龄分组而异,需要进一步调查.

科学领域:

药物监督药物监督药物监督
临床药理学临床药理学
药品安全药品安全

背景情况:

周围神经病变是一个重要的临床问题,需要早期检测.
免疫调节药物 (IMiDs) 用于治疗各种疾病.
了解IMID相关的外围神经病变对于患者的安全至关重要.

研究的目的:

为了研究特定的IMiDs (thalidomide,lenalidomide,pomalidomide) 和外围神经病变之间的关联.
量化与这些IMID相关的外围神经病变的风险信号.
确定患有IMID引起的外周神经病变风险较高的患者子组.

主要方法:

使用OpenVigil 2.1从FDA不良事件报告系统 (FAERS) 提取数据.
采用不成比例分析,包括报告概率比率 (ROR) 和信息组件 (IC),以检测安全信号.
通过使用临床评分表来优先考虑外围神经病变信号.

主要成果:

在thalidomide,lenalidomide,pomalidomide和外围神经病变之间发现了显著的关联.
对于所有三种IMiD,外围神经病变被确定为具有中等临床优先级的安全信号.
与非血细胞髓瘤患者相比,在接受thalidomide和lenalidomide治疗的血细胞髓瘤患者中观察到外围神经病变的报道增加.

结论:

与IMiD相关的外围神经病变风险因特定药物,患者的适应症和年龄而异.
在每个IMiD的特定年龄组中检测到外围神经病变风险信号.
需要进一步的研究来验证这些发现,并完善风险管理策略.

关键词:

数据库数据库数据库是一个数据库.美国食品和药物管理局的不良事件报告系统.免疫调节药物免疫调节药物周围神经病变是一种神经病变.药监测分析药监分析信号处理信号处理

更多相关视频

Nerve Ultrasound Protocol to Detect Dysimmune Neuropathies

Nerve Ultrasound Protocol to Detect Dysimmune Neuropathies

Published on: October 7, 2021

Cell Subtype-specific Analysis of Neuronal Membrane Proteasome in Somatosensory Neurons

Cell Subtype-specific Analysis of Neuronal Membrane Proteasome in Somatosensory Neurons

Published on: October 10, 2025

相关概念视频

Drug Regulation

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...

Pharmacovigilance

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...